Laboratory of Biochemical Pharmacology PAS

Dear Colleagues, According to the World Health Organization, severe depression is expected to become the leading cause of morbidity around the world by 2030. The development of the COVID-19 pandemic is certain to contribute to many disorders, from post-traumatic stress disorders and anxiety to depression. All studies to date indicate that women are more than twice as likely to develop depression. In addition, being a woman increases the likelihood of anxiety disorders by 85%. Neurohormones, which are often activated under stress, can also have a significant impact on the development of these conditions. Chronic stress consequently leads to the dysregulation of neurohormones, which can lead to the development of depression and anxiety. It therefore seems important to draw attention to the involvement of neurohormones in the development of mood disorders, especially since women's hormonal system changes many times during their lives. Therefore, I invite and encourage all authors who